Targeted Therapies in Oncology
October 2, 2022
Volume: 11
Issue: 14
September 2022
Volume: 11
Issue: 12
August 2022
Volume: 11
Issue: 11
July 1, 2022
Volume: 11
Issue: 9
July 2, 2022
Volume: 11
Issue: 10
June 1, 2022
Volume: 11
Issue: 8
May 2022
Volume: 11
Issue: 7
April 2, 2022
Volume: 6
April 1, 2022
Volume: 11
Issue: 5
March 2022
Volume: 11
Issue: 4
February 2, 2022
Volume: 11
Issue: 3
February 1, 2022
Volume: 11
Issue: 2
January 2022
Volume: 11
Issue: 1
December 1, 2021
Volume: 10
Issue: 7
December 2, 2021
Volume: 10
Issue: 18
November 1, 2021
Volume: 1
Issue: 1
October 2, 2021
Volume: 10
Issue: 14
October 1, 2021
Volume: 10
Issue: 13
September 2021
Volume: 10
Issue: 12
August 2021
Volume: 10
Issue: 11
July 1 2021
Volume: 10
Issue: 9
July 2 2021
Volume: 10
Issue: 10
June 2021
Volume: 10
Issue: 8
May 2021
Volume: 10
Issue: 7
April 2, 2021
Volume: 10
Issue: 6
April 1, 2021
Volume: 10
Issue: 5
March 2021
February 2, 2021
Volume: 10
Issue: 3
February 1, 2021
Volume: 10
Issue: 2
January 2021
Volume: 10
Issue: 1
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Clears Pen Device for Interferon Therapy in Polycythemia Vera
2
FDA Rejects Edotreotide PET Imaging Kit Over Manufacturing Concerns
3
Deep Responses Support Push for CAR T-Cell Therapy in AL Amyloidosis
4
FDA Accepts RP1 BLA Resubmission for Advanced Melanoma
5